📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study. (2023)

First Author: Fang S

Attributed to: Data mining epidemiological relationships: integration of causal analysis with published evidence funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1003988

PubMed Identifier: 36595504

Publication URI: http://europepmc.org/abstract/MED/36595504

Type: Journal Article/Review

Volume: 20

Parent Publication: PLoS medicine

Issue: 1

ISSN: 1549-1277